Literature DB >> 2689135

Monoclonal antibodies. Future potential in cancer chemotherapy.

C Kosmas1, H Kalofonos, A A Epenetos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2689135     DOI： 10.2165/00003495-198938050-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  84 in total

Review 1.  Bone-marrow transplantation (first of two parts).

Authors:  E Thomas; R Storb; R A Clift; A Fefer; F L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-17       Impact factor: 91.245

Review 2.  Antibody toxin conjugates: a perspective.

Authors:  D C Blakey; E J Wawrzynczak; P M Wallace; P E Thorpe
Journal:  Prog Allergy       Date:  1988

3.  Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis.

Authors:  T Takvorian; G P Canellos; J Ritz; A S Freedman; K C Anderson; P Mauch; N Tarbell; F Coral; H Daley; B Yeap
Journal:  N Engl J Med       Date:  1987-06-11       Impact factor: 91.245

4.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

5.  Monoclonal antibody toxin conjugates for experimental graft-versus-host disease prophylaxis. Reagents selectively reactive with T cells and not murine stem cells.

Authors:  D A Vallera; R J Youle; D M Neville; C C Soderling; J H Kersey
Journal:  Transplantation       Date:  1983-07       Impact factor: 4.939

6.  Phase II clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinoma.

Authors:  H F Sears; D Herlyn; Z Steplewski; H Koprowski
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

7.  Antitumor xenograft activity with a conjugate of a Vinca derivative and the squamous carcinoma-reactive monoclonal antibody PF1/D.

Authors:  D A Johnson; B C Laguzza
Journal:  Cancer Res       Date:  1987-06-15       Impact factor: 12.701

8.  Studies of methotrexate-monoclonal antibody conjugates for immunotherapy.

Authors:  J Kanellos; G A Pietersz; I F McKenzie
Journal:  J Natl Cancer Inst       Date:  1985-08       Impact factor: 13.506

9.  Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein.

Authors:  P Horan Hand; D Colcher; D Salomon; J Ridge; P Noguchi; J Schlom
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

10.  Antitumour reactions of monoclonal antibody against a human osteogenic-sarcoma cell line.

Authors:  M J Embleton; B Gunn; V S Byers; R W Baldwin
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640
View more
  1 in total

Review 1.  New peptide and protein drugs.

Authors:  P Vermeij; D Blok
Journal:  Pharm World Sci       Date:  1996-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.